President Obama signed an executive order aimed at preventing shortages of prescription drugs.
The order broadens reporting of potential shortages of certain prescription drugs; speeds reviews of applications to begin or alter production of these drugs; and provides more information to the Justice Department about possible instances of collusion or price gouging.